• 1. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 2. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361

8-Bromo-6-methylquinoline hydrochloride: A Comprehensive Overview

The compound with CAS No. 1255574-68-5, commonly referred to as 8-Bromo-6-methylquinoline hydrochloride, is a fascinating molecule that has garnered significant attention in the fields of organic chemistry and pharmacology. This compound belongs to the quinoline family, a class of heterocyclic aromatic compounds known for their diverse biological activities and applications in drug discovery. The 8-Bromo-6-methylquinoline hydrochloride structure is characterized by a quinoline ring system with bromine and methyl substituents at the 8th and 6th positions, respectively, along with a hydrochloride counterion.

Recent studies have highlighted the potential of 8-Bromo-6-methylquinoline hydrochloride as a promising candidate in the development of novel therapeutic agents. Researchers have explored its anti-inflammatory, antioxidant, and anticancer properties, making it a subject of interest in both academic and industrial research settings. The bromine substituent at the 8th position is particularly significant, as it contributes to the molecule's electronic properties and enhances its bioactivity.

The synthesis of 8-Bromo-6-methylquinoline hydrochloride involves a series of well-established organic reactions, including Friedlander synthesis and subsequent substitution reactions. The methyl group at the 6th position plays a crucial role in stabilizing the molecule's structure and influencing its pharmacokinetic properties. The hydrochloride form ensures optimal solubility and bioavailability, making it suitable for various biological assays.

In terms of biological activity, 8-Bromo-6-methylquinoline hydrochloride has demonstrated potent inhibitory effects on several key enzymes associated with inflammatory diseases and cancer progression. For instance, studies have shown that this compound can effectively inhibit cyclooxygenase (COX) enzymes, which are central to inflammation and pain signaling pathways. Additionally, its ability to modulate reactive oxygen species (ROS) levels suggests potential applications in antioxidant therapies.

Recent advancements in computational chemistry have further elucidated the molecular mechanisms underlying the bioactivity of 8-Bromo-6-methylquinoline hydrochloride. Molecular docking studies reveal that this compound interacts with critical binding sites on target proteins, such as COX-2 and other inflammatory mediators. These findings underscore its potential as a lead compound for drug development.

The pharmacokinetic profile of 8-Bromo-6-methylquinoline hydrochloride has also been extensively studied. Preclinical data indicate that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) properties, which are essential for its translation into clinical applications. Its ability to cross cellular membranes efficiently suggests that it could be effective in targeting intracellular pathogens or cancer cells.

In conclusion, 8-Bromo-6-methylquinoline hydrochloride represents a valuable addition to the arsenal of bioactive compounds being explored for therapeutic purposes. With its unique chemical structure and promising biological activities, this compound holds significant potential in addressing unmet medical needs in inflammation, cancer, and other chronic diseases. Ongoing research continues to unravel its full therapeutic potential, making it an exciting area of focus for future studies.

• 159925-47-0(Quinoline, 8-bromo-6-(bromomethyl)-)
• 159925-41-4(8-Bromo-6-isopropylquinoline)
• 1448230-55-4(8-Bromo-4,5-dimethylquinoline)
• 549494-70-4(9H-Carbazole, 1,8-dibromo-3,6-dimethyl-)
• 84839-95-2(8-Bromo-6-methylquinoline)
• 172939-50-3(8-Bromo-4-methylquinoline)
• 98203-08-8(8-BROMO-7-METHYLQUINOLINE)
• 823803-51-6(8-bromo-5-methylquinoline)
• 15936-79-5(7-Bromo-5-methylindole)
• 1081803-09-9(8-Bromoquinoline hydrochloride)